Gary A. Piazza

8.5k citations

171 papers · 6.9k indexed · h-index 48

Impact in

Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects
Cancer Research top 1%
- Cancer, Lipids, and Metabolism

Papers in

Pharmacology 59
- Inflammatory mediators and NSAID effects 47
Organic Chemistry 54
- Synthesis and biological activity 18
- Synthesis and Catalytic Reactions 13
- Chemical synthesis and alkaloids 13

Co-authors: Rifat Pamukcu Adam B. Keeton Heather N. Tinsley Bernard D. Gary William E. Grizzle Alireza Abadi Evrim Gurpinar Gerhard Sperl
Journals: Cancer Research (22 papers)Gastroenterology (8 papers)Archiv der Pharmazie (6 papers)Cancer Prevention Research (6 papers)Oncotarget (5 papers)
Partner nations: United States Egypt Germany

In The Last Decade

Gary A. Piazza

162 papers receiving 6.8k citations

Peers

Countries citing papers authored by Gary A. Piazza

Since Specialization

Citations

This map shows the geographic impact of Gary A. Piazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Piazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Piazza more than expected).

Fields of papers citing papers by Gary A. Piazza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Piazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Piazza. The network helps show where Gary A. Piazza may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary A. Piazza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary A. Piazza Line = papers co-authored together Gary A. Piazza links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents Cancers ·Miriam Tyburski, Po‐Jen Chen, van der A. Gaast, Yu‐Chieh Su, Ming‐Hua Shiao, Gary A. Piazza, Alireza Abadi, Matthias Engel, Mohammad Abdel‐Halim	2024	2
2	Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment PLoS ONE ·Ahmad Alhowail, Federico Tzunux Tzoc, Jenna Bloemer, Priyanka D. Pinky, Lauren N. Woodie, Subhrajit Bhattacharya, Dwipayan Bhattacharya, Manal Buabeid, B. F. Smith, Muralikrishnan Dhanasekaran, Gary A. Piazza, Miranda N. Reed, Martha Escobar, Robert D. Arnold, Vishnu Suppiramaniam	2023	3
3	Abstract 4140: Oncogenic KRAS inhibition with ADT-007 primes T cell responses in pancreatic ductal adenocarcinoma Cancer Research ·Jeremy B. Foote, Ana Sánchez Barrio, Adam B. Keeton, Padilla Cordova, Yulia Maxuitenko, Xi Chen, Susan Tselos, Donald J. Buchsbaum, Gary A. Piazza, Bassel F. El‐Rayes	2023	2
4	Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy Journal for ImmunoTherapy of Cancer ·Nada S. Aboelella, James J. Mccoart, 小田慈, Leslie L. Robison, Zhi‐Chun Ding, Hongyan Xu, Gregory S. Gorman, Roni J. Bollag, Marco L. Davila, Locke J. Bryan, David H. Munn, Gary A. Piazza, Gang Zhou	2022	10
5	The path to the clinic: a comprehensive review on direct KRASG12C inhibitors Journal of Experimental & Clinical Cancer Research ·STEPHANIE D. MASON, Gary A. Piazza, Adam B. Keeton, Caio A. Leite	2022	109
6	From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity Journal of Medicinal Chemistry ·Mohammad Abdel‐Halim, P. Gaeberlein, Sara Filipa Marques Caetano de Sousa, Amr Hefnawy, 望月あやの, Muhammad Shahzeb Khan, Ahmed Maher, Yulia Maxuitenko, Adam B. Keeton, Rolf W. Hartmann, Matthias Engel, Gary A. Piazza, Alireza Abadi	2021	19
7	PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity Drug Discovery Today ·Gary A. Piazza, Gabriely Cristina Agostineto, Xi Chen, Yulia Maxuitenko, Carvalho Marino, Nada S. Aboelella, Donald J. Buchsbaum, Michael R. Boyd, Adam B. Keeton, Gang Zhou	2020	51
8	Persistent STAT5 activation reprograms the epigenetic landscape in CD4 ⁺ T cells to drive polyfunctionality and antitumor immunity Science Immunology ·Zhi-Chun Ding, Huidong Shi, Nada S. Aboelella, Nelson Horatio Darton, Su Bin Lee, Zhuoqi Liu, Lirong Pei, Jiaqi Li, Richard McIndoe, Hongyan Xu, Gary A. Piazza, Bruce R. Blazar, David H. Munn, Gang Zhou	2020	50
9	Targeting cGMP/PKG signaling for the treatment or prevention of colorectal cancer with novel sulindac derivatives lacking cyclooxygenase inhibitory activity Gary A. Piazza, Xi Chen, Gabriely Cristina Agostineto, Carvalho Marino, Gang Zhou, Donald J. Buchsbaum, Yulia Maxuitenko, Adam B. Keeton	2020	5
10	Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitors Archiv der Pharmazie ·合澤亮, Rowaida A. El‐Sakhawy, Mohammad Abdel‐Halim, Kevin Lee, Gary A. Piazza, Christian Ducho, Rolf W. Hartmann, Alireza Abadi	2018	15
11	Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α Cancer Research ·Sangbin Lim, Hao Liu, Luciana Madeira da Silva, Ritu Arora, Zixing Liu, Joshua B. Phillips, David Schmitt, Tung Duy Vu, Steven McClellan, Yifeng Lin, Wensheng Lin, Gary A. Piazza, Øystein Fodstad, Ming Tan	2016	127
12	Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53 Bioorganic & Medicinal Chemistry ·Mohammad Abdel‐Halim, Adam B. Keeton, Evrim Gurpinar, Bernard D. Gary, Simon Vogel, Matthias Engel, Gary A. Piazza, Frank M. Boeckler, Rolf W. Hartmann, Alireza Abadi	2013	5
13	Design of Novel β‐Carboline Derivatives with Pendant 5‐Bromothienyl and Their Evaluation as Phosphodiesterase‐5 Inhibitors Archiv der Pharmazie ·Kwangtaek Sim, K.R. Kropp, Bernard D. Gary, Gary A. Piazza, Matthias Engel, Rolf W. Hartmann, Alireza Abadi	2013	14
14	Aquaporins mediate the chemoresistance of human melanoma cells to arsenite Molecular Oncology ·Lin Gao, Yanhui Gao, Zheng‐Xiang Li, Paul Howell, Rajeev Kumar, Xiulan Su, Alexander V. Vlassov, Gary A. Piazza, Adam I. Riker, Dianjun Sun, Yaguang Xi	2011	42
15	Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective European Journal of Medicinal Chemistry ·Alireza Abadi, Bernard D. Gary, Heather N. Tinsley, Gary A. Piazza, Mohammad Abdel‐Halim	2010	41
16	Design, Synthesis and Structure–Activity Relationship of Functionalized Tetrahydro‐β‐carboline Derivatives as Novel PDE5 Inhibitors Archiv der Pharmazie ·K.R. Kropp, Bernard D. Gary, Heather N. Tinsley, Gary A. Piazza, Stefan Laufer, Alireza Abadi	2010	25
17	Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation European Journal of Pharmacology ·Wenyan Lü, Heather N. Tinsley, Adam B. Keeton, Zhican Qu, Gary A. Piazza, Yonghe Li	2008	94
18	Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells PubMed ·Andrew K. Joe, Hui Liu, Danhua Xiao, Jae‐Won Soh, John T. Pinto, David G. Beer, Gary A. Piazza, William J. Thompson, I. Bernard Weinstein	2003	13
19	The sulfone metabolite of sulindac (FGN-1) inhibits rat colonic carcinogenesis but does not inhibit either prostaglandin synthesis or colonic proliferation Gastroenterology ·Dennis J. Ahnen, Gary A. Piazza, М Т Хадыков, Ruth Richardson, N S Paranka, Randall W. Burt, Rifat Pamukcu	1995	3
20	Lysophosphatidic Acid Induction of Transforming Growth Factors α and β: Modulation of Proliferation and Differentiation in Cultured Human Keratinocytes and Mouse Skin Experimental Cell Research ·Gary A. Piazza, Faxin Zhang, 王世刚	1995	79

About Gary A. Piazza

Gary A. Piazza is a scholar working on Pharmacology, Organic Chemistry, Molecular Biology, Oncology and Toxicology, having authored 171 papers that have together received 6.9k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (51 papers), Inflammatory mediators and NSAID effects (47 papers), Estrogen and related hormone effects (23 papers), Synthesis and biological activity (18 papers), Synthesis and Catalytic Reactions (13 papers), Cancer Mechanisms and Therapy (13 papers), Chemical synthesis and alkaloids (13 papers) and Cancer therapeutics and mechanisms (12 papers). The work is most often cited by research in Pharmacology (2.1k citations), Cancer Research (1.1k citations), Toxicology (199 citations), Oncology (1.5k citations) and Molecular Biology (3.5k citations). Gary A. Piazza has collaborated with scholars based in United States, Egypt and Germany. Frequent co-authors include Rifat Pamukcu, Adam B. Keeton, Heather N. Tinsley, Bernard D. Gary, William E. Grizzle, Alireza Abadi, Evrim Gurpinar, Gerhard Sperl, N S Paranka and Alexandra M. Fajardo. Their work appears in journals such as Cancer Research, Gastroenterology, Archiv der Pharmazie, Cancer Prevention Research and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact